Arabic Arabic English English French French German German
dark

Xeltis Initiates First-ever Pivotal Trial of a Synthetic Restorative Pulmonary Heart Valve

Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, announced that it has started the first-ever pivotal trial for a synthetic restorative pulmonary valve. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

QIAGEN’s NeuMoDx™ HAdV Quant Assay Secures CE-IVD Certification for Automated Testing to Detect Human Adenovirus Infections

Next Post

What is the evidence on how to improve older adults’ functional abilities at home?

Related Posts
Total
0
Share